Inclusion criteria |
 Age between 40 and 70 years |
 Diagnosis of COPD or at risk for COPD |
 Smoking History >10 pack years (for nonsmokers less than 100 cigarettes in lifetime) |
 FEV1 30–60 % (COPD group), normal FEV1 (Healthy Smoker Group) |
 English speaking |
Exclusion criteria |
 Diagnosis of chronic sinusitis or allergic rhinitis |
 Presence of other lung disease (including asthma) |
 Pregnancy |
 Sinusitis or URI within the last 6 weeks |
 COPD Exacerbation within 6 weeks of screening visit |
 Presence of infiltrate or mass on CT scan |
 Anticoagulation or antiplatelet therapy within 6 half lives of bronchoscopy |
 Known allergy to lidocaine |
 Predisposition to bleeding |
 Chronic treatment with steroids, oral or inhaled that cannot be discontinued for 4 weeks prior to study |
 Unwillingness to participate in study |